Evidence map›Paper›PMID 37513861›Full record

ArticlePharmaceuticals (Basel, Switzerland)2023

Preparation of Selenium-Based Drug-Modified Polymeric Ligand-Functionalised Fe

Itziar Galarreta-Rodriguez, Mikel Etxebeste-Mitxeltorena, Esther Moreno, Daniel Plano, Carmen Sanmartín, Saad Megahed, Neus Feliu, Wolfgang J Parak, Eneko Garaio, Izaskun Gil de Muro and 3 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Pharmaceuticals (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Itziar Galarreta-RodriguezDepartamento Química Orgánica e Inorgánica, Facultad de Ciencia y Tecnología, University of the Basque Country (UPV/EHU), Sarriena s/n, 48940 Leioa, Spain.
Mikel Etxebeste-MitxeltorenaDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.
Esther MorenoTropical Health Institute of the University of Navarra (ISTUN), University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-8446-4608
Daniel PlanoDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0002-8266-0445
Carmen SanmartínDepartment of Pharmaceutical Technology and Chemistry, University of Navarra, Irunlarrea 1, 31008 Pamplona, Spain.ORCID 0000-0003-3431-7826
Saad MegahedFachbereich Physik, Universität Hamburg, 22761 Hamburg, Germany.ORCID 0000-0001-8556-5710
Neus FeliuCenter for Applied Nanotechnology CAN, Fraunhofer Institute for Applied Polymer Research IAP, 20146 Hamburg, Germany.ORCID 0000-0002-7886-1711
Wolfgang J ParakFachbereich Physik, Universität Hamburg, 22761 Hamburg, Germany.ORCID 0000-0003-1672-6650
Eneko GaraioDepartamento de Ciencias, Universidad Pública de Navarra, Campus Arrosadía, 31006 Pamplona, Spain.
Izaskun Gil de MuroDepartamento Química Orgánica e Inorgánica, Facultad de Ciencia y Tecnología, University of the Basque Country (UPV/EHU), Sarriena s/n, 48940 Leioa, Spain.ORCID 0000-0002-5277-7386
Luis LezamaDepartamento Química Orgánica e Inorgánica, Facultad de Ciencia y Tecnología, University of the Basque Country (UPV/EHU), Sarriena s/n, 48940 Leioa, Spain.ORCID 0000-0001-6183-2052
Idoia Ruiz de LarramendiDepartamento Química Orgánica e Inorgánica, Facultad de Ciencia y Tecnología, University of the Basque Country (UPV/EHU), Sarriena s/n, 48940 Leioa, Spain.ORCID 0000-0002-4179-7357
Maite InsaustiDepartamento Química Orgánica e Inorgánica, Facultad de Ciencia y Tecnología, University of the Basque Country (UPV/EHU), Sarriena s/n, 48940 Leioa, Spain.ORCID 0000-0002-3019-0242

Funding

Basque Government GIC-IT-1546-22Cluster of Excellence Advanced Imaging of Matter of the Deursche Forschungsgemeinschaft ID 390715994Ministry of Economy and Competitiveness PID2019-106845RB-100 (AEI/FEDER, UE)
6 · The paper itself

Abstract

In recent years, much effort has been invested into developing multifunctional drug delivery systems to overcome the drawbacks of conventional carriers. Magnetic nanoparticles are not generally used as carriers but can be functionalised with several different biomolecules and their size can be tailored to present a hyperthermia response, allowing for the design of multifunctional systems which can be active in therapies. In this work, we have designed a drug carrier nanosystem based on Fe

Indexed as

drug carriersmagnetic hyperthermia inductormagnetic nanoparticles

Identifiers

PMID37513861
PMCPMC10385492

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.